General Information of the Compound
Compound ID |
CP0908982
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(+/-)-5,5-difluoro-7-(4-(2-(6-(8-(2-hydroxy-3-(naphthalen-1-yloxy)propylamino)octylamino)-6-oxohexylamino)-2-oxoethoxy)styryl)-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C50H58BF2N5O5S
|
||||||||||||||||||
Molecular Weight |
889.919
|
||||||||||||||||||
Canonical SMILES |
O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNCC(O)COc1cccc2ccccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C50H58BF2N5O5S/c52-51(53)57-40(24-25-41(57)34-42-26-29-46(58(42)51)48-18-13-33-64-48)23-20-38-21-27-44(28-22-38)62-37-50(61)56-32-11-5-6-19-49(60)55-31-10-4-2-1-3-9-30-54-35-43(59)36-63-47-17-12-15-39-14-7-8-16-45(39)47/h7-8,12-18,20-29,33-34,43,54,59H,1-6,9-11,19,30-32,35-37H2,(H,55,60)(H,56,61)/b23-20+
Show/Hide
|
||||||||||||||||||
InChIKey |
SMVONLFCHHISHK-BSYVCWPDSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor